MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1583.46%
Quick Ratio
1583.46%
Cash Ratio
369.42%
Debt to Asset Ratio
4.77%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
176,032
220,449
Short-term marketable securities
561,794
521,866
Prepaid expenses and other current assets
16,709
22,285
Total current assets
754,535
764,600
Long-term marketable securities
250,490
343,931
Right of use asset
552
621
Total assets
1,005,577
1,109,152
Accounts payable
20,399
13,249
Loan payable, current
-
13,501
Accrued expenses and other current liabilities
27,252
33,651
Total current liabilities
47,651
60,401
Operating lease liability, noncurrent
289
372
Loan payable, noncurrent
-
22,160
Warrant liability
-
400
Total liabilities
47,940
83,333
Common stock, 0.0001 par value, 150,000,000 shares authorized as of september 30, 2025 and december 31, 2024 80,149,218 and 72,383,013 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
8
8
Additional paid-in capital
2,004,755
1,992,209
Accumulated other comprehensive income
1,826
988
Accumulated deficit
-1,048,952
-967,386
Total stockholders' equity
957,637
1,025,819
Total liabilities and stockholders' equity
1,005,577
1,109,152
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$561,794K Cash and cashequivalents$176,032K Prepaid expenses andother current assets$16,709K Total current assets$754,535K Long-term marketablesecurities$250,490K Right of use asset$552K Total assets$1,005,577K Total liabilities andstockholders' equity$1,005,577K Total stockholders'equity$957,637K Total liabilities$47,940K Accumulated deficit-$1,048,952K Additional paid-in capital$2,004,755K Total currentliabilities$47,651K Operating leaseliability, noncurrent$289K Accumulated othercomprehensive income$1,826K Common stock, 0.0001par value,...$8K Accrued expenses andother current...$27,252K Accounts payable$20,399K

Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics, Inc. (AKRO)